Peng, Ying

L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice. [electronic resource] - Journal of Alzheimer's disease : JAD 2012 - 379-91 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1875-8908

10.3233/JAD-2011-111577 doi


Alzheimer Disease--complications
Amyloid beta-Peptides--metabolism
Amyloid beta-Protein Precursor--genetics
Analysis of Variance
Animals
Benzofurans--pharmacology
Brain--drug effects
Cell Line, Tumor
Cognition Disorders--drug therapy
Cyclin-Dependent Kinase 5--metabolism
Disease Models, Animal
Gene Expression Regulation--drug effects
Glycogen Synthase Kinase 3--metabolism
Glycogen Synthase Kinase 3 beta
Humans
Male
Maze Learning--drug effects
Mice
Mice, Transgenic
Neuroblastoma--pathology
Neuroprotective Agents--pharmacology
Phosphorylation--drug effects
Presenilin-1--genetics
Reaction Time--drug effects
Spatial Behavior--drug effects
Time Factors
tau Proteins--metabolism